Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

MDXG
MiMedx Group, Inc
stock NASDAQ

At Close
Jul 29, 2026 3:59:57 PM EDT
4.22USD-3.211%(-0.14)1,413,915
3.68Bid   4.93Ask   1.25Spread
Pre-market
Jul 27, 2026 8:15:30 AM EDT
4.25USD+1.190%(+0.05)0
After-hours
Jul 29, 2026 4:54:30 PM EDT
4.13USD-2.133%(-0.09)41,733
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 28, 2022
12:40PM EST  MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), a transformational placental biologics company, today announced that a federal court in Georgia has denied a motion to reconsider the dismissal of Carpenters Pension Fund of Illinois (CPFI) putative class action lawsuit claiming that the Company violated the federal securities laws.   GlobeNewswire Inc
Jan 25, 2022
04:12AM EST  MDXG: Model Updates   Benzinga
Jan 12, 2022
10:52AM EST  MDXG: New Year's Resolutions   Benzinga
Jan 10, 2022
08:16AM EST  MIMEDX Sees FY22 Annual Revenue Growth Of 11%-14%; Sees Advanced Wound Care/Section 361 Adj. Revenue $236M-$240M   Benzinga
08:00AM EST  MIMEDX Primed to Commence Pivotal Phase 3 Clinical Study Program of micronized dehydrated Human Amnion Chorion Membrane (mdHACM) in Knee Osteoarthritis (KOA), Targeting Potential Late-2026 Commercial Launch   GlobeNewswire Inc
Jan 4, 2022
04:05PM EST  MIMEDX to Participate at the H.C. Wainwright BioConnect Virtual   GlobeNewswire Inc
Dec 22, 2021
08:00AM EST  MIMEDX to Present at the 40th Annual J.P. Morgan Healthcare Conference   GlobeNewswire Inc
Dec 7, 2021
07:00AM EST  Company to Share Probability Values from its Knee Osteoarthritis (KOA) Study; Analyses Conducted Support Confidence in Initiation of Confirmatory Phase 3 Trials in 2022   GlobeNewswire Inc
Nov 30, 2021
08:00AM EST  Company to Host Virtual Event on December 7, 2021 Beginning at 9:00 a.m. ET   GlobeNewswire Inc
Nov 22, 2021
08:00AM EST  MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, and Rohit Kashyap, Ph.D., Chief Commercial Officer, will present at the Piper Sandler 33rd Annual Healthcare Conference taking place November 29 to December 2, 2021.   GlobeNewswire Inc
Nov 17, 2021
08:12AM EST  MiMedx Group Says Peer Reviewed Study Demonstrates MIMEDX Dehydrated Human Amnion Chorion Membrane (dHACM) Outperforms Standard Of Care In Select Mohs Defect Reconstructions   Benzinga
08:00AM EST  MIMEDX PURION Processed Placental Allografts Proved Safer Than Autologous Tissue, Reducing Infection, Scarring and Reoperation Rates   GlobeNewswire Inc
Nov 10, 2021
05:02AM EST  MDXG: Third Quarter Results   Benzinga
Nov 2, 2021
06:22PM EDT  MIMEDX Sees FY21 Sales $245M-$255M vs $250.8M Estimate   Benzinga
06:15PM EDT  MiMedx Group Q3 EPS $(0.04) Beats $(0.08) Estimate, Sales $63.07M Beat $60.26M Estimate   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
08:00AM EDT  MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Rohit Kashyap, Ph.D., Chief Commercial Officer, will be participating in the following virtual investor conferences:   GlobeNewswire Inc
Nov 1, 2021
08:30AM EDT  Data Show mdHACM Mitigates Effects of Inflammatory-Induced Degeneration in Chondrocytes, the Primary Cell Type in Cartilage; May Mitigate Vessel Formation and Repair   GlobeNewswire Inc
Oct 20, 2021
08:00AM EDT  MIMEDX to Host Third Quarter 2021 Operating and Financial Results   GlobeNewswire Inc
Oct 14, 2021
04:05PM EDT  MIMEDX to Host Virtual Investor Day on December 7, 2021   GlobeNewswire Inc
Oct 13, 2021
07:01AM EDT  Net Health Agreement with MIMEDX Streamlines Complex Insurance Benefits   PR Newswire
Sep 25, 2021
06:11AM EDT  MDXG: Unexpected Results Call for a Revision   Benzinga
Sep 20, 2021
10:13AM EDT  Hearing Zacks Sets $10 Price Target On MiMedx   Benzinga
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Sep 14, 2021
06:13AM EDT  HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8.5   Benzinga
Sep 13, 2021
02:40PM EDT  Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher   Benzinga
12:17PM EDT  Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet   Benzinga
10:29AM EDT  Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract   Benzinga
10:12AM EDT  Shares of MiMedx Group Inc. (MDXG) plunged nearly 60% on Monday morning after the company's late-stage trial for the treatment of plantar fasciitis failed to meet primary endpoint. The company said it will not pursue a Biologics License Application for this indication at this time.   RTTNews
09:24AM EDT  Why MiMedx Shares Are Diving Today   Benzinga
09:04AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Monday, Sept. 13, 2021: JKS, NEGG, DVAX, BLU, MDXG   Benzinga
07:49AM EDT  MiMedx: Phase 3 PF Study Fails To Meet Primary Endpoint;   RTTNews
07:03AM EDT  MIMEDX Says Phase 2B KOA Trial And Phase 3 PF Study Fail To Meet End Point   RTTNews
06:33AM EDT  MIMEDX Announces Top-Line Results From Interim Analysis Of Six-Month Efficacy Data For Phase 2B Trial For KOA Did Not Meet Primary Endpoints   Benzinga
06:30AM EDT  Phase 2B Knee Osteoarthritis (KOA) Study Top-line Interim Results Demonstrate Varied Efficacy Signals between Patient Cohorts   GlobeNewswire Inc
Sep 10, 2021
08:00AM EDT  The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test   Benzinga
Sep 9, 2021
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
07:30AM EDT  MIMEDX Announces Effectiveness of Shelf Registration Statement   GlobeNewswire Inc
Sep 7, 2021
08:00AM EDT  MIMEDX to Present at the H.C. Wainwright 23rd Annual Global   GlobeNewswire Inc
Sep 3, 2021
07:31AM EDT  The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself   Benzinga
Sep 2, 2021
08:20AM EDT  The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab   Benzinga
Sep 1, 2021
07:32AM EDT  The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering   Benzinga
Aug 31, 2021
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
Aug 27, 2021
09:00AM EDT  S-3 Eligibility Enabled by Accomplishment of Multiple Financial Milestones   GlobeNewswire Inc
08:40AM EDT  MiMedx Group Files For $350M Mixed Shelf Offering   Benzinga
07:35AM EDT  The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration   Benzinga
Aug 26, 2021
08:09AM EDT  The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO   Benzinga
Aug 25, 2021
07:30AM EDT  The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug   Benzinga
Aug 24, 2021
08:09AM EDT  The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal   Benzinga
Aug 17, 2021
08:34AM EDT  MiMedx Highlights Publication Of Study In Journal of Wound Care   Benzinga
08:30AM EDT  New study shows advanced treatment (AT) for management of LEDUs among Medicare beneficiaries is associated with significant reductions in major and minor amputation, emergency department (ED) use, and hospital readmissions vs. LEDUs managed without AT (NAT)   GlobeNewswire Inc
Aug 12, 2021
08:30AM EDT  Promotion Recognizes Skilled Leadership and Contributions to MIMEDXs Continued Growth   GlobeNewswire Inc
Aug 10, 2021
06:11AM EDT  MDXG: 2Q:21 Update   Benzinga
Aug 3, 2021
05:32PM EDT  MiMedx Group Q2 EPS $(0.03) Beats $(0.05) Estimate, Sales $68.17M Beat $60.16M Estimate   Benzinga
03:52AM EDT  Earnings Scheduled For August 3, 2021   Benzinga
Jul 26, 2021
10:29AM EDT  Northland Capital Markets Initiates Coverage On MiMedx Group with Outperform Rating, Announces Price Target of $23   Benzinga
Jul 20, 2021
08:00AM EDT  MIMEDX to Host Second Quarter 2021 Operating and Financial Results   GlobeNewswire Inc
Jul 14, 2021
09:00AM EDT  MIMEDX Applauds Dr. Laurencin on Receiving NAACPs Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing   GlobeNewswire Inc
Jul 6, 2021
04:04AM EDT  Earnings Scheduled For July 6, 2021   Benzinga
Jun 30, 2021
07:29AM EDT  The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs   Benzinga
Jun 28, 2021
08:12AM EDT  MIMEDX Joins Russell 3000 And 2000 Indexes   Benzinga
08:00AM EDT  MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today confirmed that FTSE Russell will add the Companys common stock to its broad-market Russell 3000 and Russell 2000 Indexes effective after the U.S. market opens today, June 28, as part of the 2021 Russell indexes reconstitution.   GlobeNewswire Inc
Jun 15, 2021
05:01PM EDT  MiMedx Group Reports New Study Showed Potential For MIMEDX Purion Processed Dehydrated Human Amnion/Chorion Membrane To Modulate Pathological Scar Tissue Formation   Benzinga
04:54PM EDT  Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing Response   GlobeNewswire Inc
Jun 8, 2021
08:35AM EDT  MIMEDX Reports Received Regulatory Approval To Commercialize EPIFIX In Japan; Sees Availability Early 2022   Benzinga
08:30AM EDT  MIMEDX Receives Regulatory Approval to Commercialize   GlobeNewswire Inc
May 27, 2021
08:00AM EDT  MIMEDX to Participate at the Jefferies Virtual Healthcare Conference   GlobeNewswire Inc
May 25, 2021
08:30AM EDT  Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern   GlobeNewswire Inc
May 12, 2021
08:00AM EDT  Vote FOR MIMEDXs Experienced and Highly Qualified Directors and Governance Enhancement Proposals   GlobeNewswire Inc
May 11, 2021
10:12AM EDT  MiMedx Group Shares Quite; Co Granted U.S. Patent Titled 'Placental tissue composition for for treating cardiac tissue damage'   Benzinga
May 10, 2021
11:41AM EDT  MDXG: Multiple Readouts This Summer   Benzinga
08:00AM EDT  MIMEDX Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will be participating in the following virtual investor conferences:   GlobeNewswire Inc
May 6, 2021
08:55AM EDT  MIMEDX Announces Collaborative Agreement with the Wake Forest Institute for Regenerative Medicine   Benzinga
08:00AM EDT  Relationship Furthers Mutual Interest in the Development and Advancement of Scientific Evidence to Support Safe and Effective Clinical Therapies   GlobeNewswire Inc
May 4, 2021
04:04PM EDT  Prescience Point Announces Withdrawal of Its Slate of Nominees to MiMedx's Board   PR Newswire
09:16AM EDT  MIMEDX Issues Note Urging Shareholders To 'Consider Prescience Point's Motivations Before Voting Their Shares At The Company's Annual Meeting'   Benzinga
09:15AM EDT  MIMEDX Urges Shareholders to Consider Prescience   GlobeNewswire Inc
May 3, 2021
08:35AM EDT  MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders   Benzinga
08:03AM EDT  Urges Shareholders to Vote the WHITE Proxy Card FOR ALL Four of MIMEDXs Director Nominees Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner   GlobeNewswire Inc
Apr 29, 2021
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
Apr 28, 2021
05:20PM EDT  MiMedx Group Q1 EPS $(0.09) Beats $(0.19) Estimate, Sales $60.00M Beat $59.90M Estimate   Benzinga
10:25AM EDT  MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice   GlobeNewswire Inc
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
04:15AM EDT  Earnings Scheduled For April 28, 2021   Benzinga
Apr 25, 2021
11:41AM EDT  MDXG: Last Patients, Last Visits in Late-stage Trials   Benzinga
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 22, 2021
08:00AM EDT  MiMedx to Host First Quarter 2021 Operating and Financial Results   GlobeNewswire Inc
Apr 19, 2021
09:07AM EDT  MiMedx Announces Last Patients Last Visits In Three Late-Stage Musculoskeletal Trials with Proprietary Tissue Technology   Benzinga
09:00AM EDT  Advances Potential for Use of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) as a Safe and Effective Treatment Option   GlobeNewswire Inc
Apr 16, 2021
12:07PM EDT  MiMedx Confirms Receipt of Director Nominations from Prescience   GlobeNewswire Inc
07:46AM EDT  Prescience Point Capital Management To Nominate Four Highly Qualified Director Candidates To MiMedx Board   RTTNews
07:40AM EDT  Prescience Point Capital Management Appoints Four Candidates To MiMedx Board   Benzinga
07:30AM EDT  Prescience Point Capital Management to Nominate Four Highly Qualified Director   PR Newswire
Apr 14, 2021
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
Apr 13, 2021
08:16AM EDT  The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug   Benzinga
Apr 8, 2021
08:14AM EDT  The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data   Benzinga
Apr 7, 2021
07:58AM EDT  The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award   Benzinga
Apr 6, 2021
08:05AM EDT  The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout   Benzinga
Mar 30, 2021
09:45AM EDT  MiMedx Group Granted U.S. Patent Titled 'Compositions and methods of treatment with amniotic fluid'   Benzinga
08:00AM EDT  MiMedx Awarded Amniotic Tissue Supplier Agreement with   GlobeNewswire Inc
Mar 19, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 19, 2021   Benzinga
06:44AM EDT  HC Wainwright & Co. Initiates Coverage On MiMedx Group with Buy Rating, Announces Price Target of $20   Benzinga
Mar 9, 2021
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
Mar 8, 2021
05:33PM EST  MiMedx Group Q4 EPS $(0.17) Down From $(0.07) YoY, Sales $68.55M Down From $76.40M YoY   Benzinga
05:33PM EST  Noted biopharmaceutical thought leader adds academic, research and industry expertise   GlobeNewswire Inc
05:32PM EST  Fourth Quarter Net Sales of $68.5 million, Full Year 2020 Net Sales of $248.2 million   GlobeNewswire Inc
04:05AM EST  Earnings Scheduled For March 8, 2021   Benzinga
Mar 6, 2021
10:58AM EST  The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings   Benzinga
Mar 4, 2021
08:12AM EST  The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company   Benzinga
Mar 3, 2021
08:00AM EST  MiMedx Group, Inc. (Nasdaq: MDXG) (MiMedx or the Company), an industry leader in advanced wound care and a therapeutic biologics company, today announced that management will be participating in the following virtual investor conferences:   GlobeNewswire Inc
07:46AM EST  The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study   Benzinga
Mar 2, 2021
08:01AM EST  MiMedx to Host Fourth Quarter and Full Year 2020 Operating and   GlobeNewswire Inc
Feb 26, 2021
03:00AM EST  National law firm Barr Law Group is investigating the actions of the officers and board of directors of NantKwest, Inc., Infinity Q Diversified Alpha Fund, JELD-WEN Holding, Inc., and MiMedx Group, Inc. If you are a current owner of shares of any of these stocks, contact leo@barrlaw.com or call (619) 400-4966.   GlobeNewswire Inc
Feb 10, 2021
08:00AM EST  MiMedx to Participate at the BTIG Virtual MedTech, Digital Health,   GlobeNewswire Inc
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Jan 11, 2021
06:22AM EST  MiMedx Group Inc Sees FY21 Net Sales Of $235M-$250M Assuming Full Impact And $255M-$270M Assuming No Impact   Benzinga
Jan 8, 2021
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 6, 2021
08:00AM EST  Reminder: MiMedx to Present at the 39th Annual J.P. Morgan   GlobeNewswire Inc
Jan 4, 2021
08:00AM EST  MiMedx to Participate at the H.C. Wainwright BioConnect 2021   GlobeNewswire Inc
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 16, 2020
09:17AM EST  MiMedix Group Shares Quiet; Prescience Point Capital Raises Price Target To $31   Benzinga
09:14AM EST  Prescience Point Capital Management Raises Price Target on MiMedx Group to $31   PR Newswire
Dec 7, 2020
08:00AM EST  MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference   GlobeNewswire Inc
Dec 1, 2020
09:22AM EST  Experienced Healthcare Executive Will Expand Companys Visibility Within the Financial Community   GlobeNewswire Inc
Nov 24, 2020
05:15PM EST  MiMedx Group, Inc. (Nasdaq: MDXG) (MiMedx or the Company), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will present at the Piper Sandler 32nd Annual Virtual Healthcare Conference taking place December 1-3, 2020.   GlobeNewswire Inc
Nov 13, 2020
08:00AM EST  MiMedx To Host Virtual 2020 Annual Meeting of Shareholders on   GlobeNewswire Inc
Nov 12, 2020
08:00AM EST  MiMedx To Present At Canaccord Genuity Virtual MedTech &   GlobeNewswire Inc
Nov 5, 2020
09:35AM EST  'We continue to own 8,750,750 shares of $MDXG. We believe the equity has tremendous upside...' -Tweet From Prescience Point   Benzinga
Nov 4, 2020
04:07PM EST  Third Quarter Net Sales of $64.3Million, Above Preliminary Range   GlobeNewswire Inc
08:00AM EST  MiMedx To Advance the Conversation of Study Bias in the Clinical   GlobeNewswire Inc
Nov 3, 2020
05:32PM EST  MiMedx Shares Will Begin To Trade On Nasdaq Starting Wednesday, Nov. 4, 2020   Benzinga
05:31PM EST  MiMedx Group, Inc. (OTC PINK: MDXG) (MiMedx or the Company), an industry leader in advanced wound care and a therapeutic biologics company, today confirmed that the Companys common stock will commence trading on The Nasdaq Stock Market at the opening of trading on Wednesday, November 4, 2020, under the ticker symbol MDXG.   GlobeNewswire Inc
08:00AM EST  MiMedx Announces Largest U.S. Commercial Payor Will Provide   GlobeNewswire Inc
Oct 30, 2020
04:52PM EDT  MiMedx Announces Relisting on Nasdaq   GlobeNewswire Inc
Oct 15, 2020
08:23AM EDT  MiMedx Files Definitive Proxy Materials   GlobeNewswire Inc
Sep 24, 2020
07:05AM EDT  - John M. Gay, Vice President, Finance and Corporate Controller with over 20 years of financial and accounting experience appointed as Chief Financial Officer   GlobeNewswire Inc
Sep 21, 2020
08:33AM EDT  MiMedx Concludes Enrollment For Phase 2B Study Of Osteoarthritis Of The Knee   RTTNews
08:30AM EDT  Research Advances Understanding of Amniotic Tissue as Potential Unique Treatment for Painful Chronic Condition that Affects 242 Million People Globally   GlobeNewswire Inc
06:39AM EDT  MiMedx Group Expects Q3 Net Sales To Be $61 Mln- $64 Mln   RTTNews
06:15AM EDT  Third Quarter 2020 Net Sales Expected to be Between $61 Million - $64 Million   GlobeNewswire Inc
Sep 17, 2020
11:00AM EDT  Research in Plantar Fasciitis Advances Understanding of Amniotic Tissue as Potential Treatment for Chronic Musculoskeletal Pain and Function Disorders   GlobeNewswire Inc
Sep 14, 2020
08:00AM EDT  New Allograft Expands to Twice its Size and Provides a Protective Structure to Support the Wound Healing Cascade   GlobeNewswire Inc
Aug 24, 2020
09:00AM EDT  MiMedx to Discuss Strategic Priorities at Upcoming Virtual 2019   GlobeNewswire Inc
Aug 10, 2020
09:00AM EDT  MiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized   GlobeNewswire Inc
Aug 3, 2020
08:07AM EDT  MiMedx Files Definitive Proxy Materials   GlobeNewswire Inc
Jul 28, 2020
07:30AM EDT  MiMedx Adds Rohit Kashyap, Ph.D., to Leadership Team as Executive   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC